Medidata Solutions (Medidata), a leading provider of clinical trial solutions to the life sciences industry, that is part of Dassault Systèmes, has won two awards in the 2024 Pharmaceutical Technology Excellence Awards, in the Innovation and Product Launches categories, for its innovative digital solutions.
The Pharmaceutical Technology Excellence Awards celebrate the greatest achievements and innovations in the pharmaceutical industry. Powered by GlobalData’s business intelligence, the Awards recognize the people and companies that are driving change in the industry.
Go deeper with GlobalData
Medidata secured the Innovation award for its Health Record Connect, a cutting-edge interoperability engine that streamlines electronic health record (EHR) data acquisition and exchange, and the Product Launch award for its Clinical Data Studio, which revolutionizes data management by integrating diverse data sources and applying artificial intelligence (AI) to enhance data quality and efficiency.Â
Revolutionizing clinical trials with Health Record Connect
Medidata’s Health Record Connect stands out for its ability to securely acquire, transform, and exchange electronic health record (EHR) data across healthcare organizations. By creating the first scalable solution that bridges clinical research with healthcare data, Medidata has paved the way for a more integrated and efficient approach to clinical trials.
The interoperability engine for Health Record Connect is designed to enable faster completion of Electronic Data Capture (EDC) forms by leveraging existing patient health record data. This significantly reduces the manual data entry efforts typically required in clinical trials, thereby streamlining the data collection process. The solution’s immediate operability eliminates the need for complex site-by-site integrations or data transfer agreements, further enhancing its appeal to healthcare organizations and clinical researchers alike.
Transforming data management with Clinical Data Studio
In the category of Product Launches, Medidata’s Clinical Data Studio has been recognized for its outstanding contribution to data management. The unified platform has transformed the way clinical research data is managed by integrating data from various sources and employing artificial intelligence to enhance data quality and workflow efficiency.
Clinical Data Studio’s impact on data review and reconciliation times is profound, with reductions of up to 80%, and a 50% decrease in patient profile review time. These efficiencies are achieved through a user-friendly, no/low code environment that streamlines data aggregation, standardization, and management workflows. Additionally, the introduction of Medidata Data Surveillance and Medidata Data Quality Management supports a holistic approach to data quality and risk-based quality management (RBQM), further solidifying the platform’s position as a leader in the field.
Medidata’s solutions, thus, demonstrate a deep understanding of the challenges faced by clinical researchers and a commitment to providing tools that enhance efficiency, reduce costs, and ultimately improve patient outcomes.
“We’re honored to be recognized by Pharmaceutical Technology for Clinical Data Studio and Health Record Connect. Through these innovative solutions, Medidata is helping customers streamline efforts at clinical research sites, reduce study costs, and improve patient outcomes.” – Anthony Costello, CEO, Medidata
Company Profile
Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 34,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,200 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.
Contact Details
Website: https://www.medidata.com/
Links
